Identification of plumericin as a potent new inhibitor of the NF-κB pathway with anti-inflammatory activity in vitro and in vivo.
Fakhrudin N, Waltenberger B, Cabaravdic M, Atanasov AG, Malainer C, Schachner D, Heiss EH, Liu R, Noha SM, Grzywacz AM, Mihaly-Bison J, Awad EM, Schuster D, Breuss JM, Rollinger JM, Bochkov V, Stuppner H, Dirsch VM.
Fakhrudin N, et al. Among authors: liu r.
Br J Pharmacol. 2014 Apr;171(7):1676-86. doi: 10.1111/bph.12558.
Br J Pharmacol. 2014.
PMID: 24329519
Free PMC article.